The 1st European Myeloma Network (EMN) Meeting 2018, held in Turin, Italy, took place on the 19–21 April. EMN 2018 hosted leading specialists in multiple myeloma (MM), who presented the latest research in this ever-evolving field.
Our coverage of this year’s conference includes a special interview with Robert Kyle about his work, which culminated in a much clearer understanding of the progression and risk factors for MM. Other highlights include advances in novel therapies and arguments for using patient fitness as a criterion for treatment rather than age.
Highlighted topics to explore include measurable residual disease, immunotherapy, transplantation and other monoclonal gammopathies, such as smoldering multiple myeloma, MGUS and amyloidosis. Watch those at the forefront of research cover these exciting topics right here.
By choosing to continue, you are confirming that you are a healthcare professional
Keep up to date with all the latest news with our monthly newsletter